Current Members

Principal Investigator

Nenad Bursac

Professor of Biomedical Engineering

nenad_dot_bursac_@_duke_dot_edu

(919) 660-5510

Embryonic and adult stem cell therapies for heart and muscle disease; cardiac and skeletal muscle tissue engineering; cardiac electrophysiology and arrhythmias; genetic modifications of stem and somatic cells; micropatterning of proteins and hydrogels.

Research Scientists

Karen Heman

karen.heman@duke.edu

I will be performing rodent surgeries to support cardiac and skeletal muscle studies.

Renzhi Zhan

zhan0001@duke.edu

I am working on human engineered skeletal and cardiac muscle for organ-on-chip studies.

Laboratory Staff

Caroline Curtis

Associate in Research

caroline.curtis@duke.edu

Amulya Kaza

Associate in research

amulya.kaza@duke.edu

I work on human skeletal muscle tissue engineering.

Sumie Okuwa

Lab Manager

sumie.okuwa@duke.edu

I am the lab manager for the Bursac Lab, and I also assist lab members with molecular biology and cell culture.

Jessica Woodard

Associate in Research

jessica.woodard@duke.edu

Post-Doctoral Associates

Alastair Khodabukus

alastair.khodabukus@duke.edu

I work on developing more physiologically relevant tissue engineered skeletal muscle to study both healthy and diseased muscle physiology in human and rat cells.

Hanjun Li

hanjun.li@duke.edu

I study the mechanisms of ion channel trafficking in reponse to biomechanical cues.

Hung Nguyen

hung.nguyen@duke.edu

I work on designing and engineering electrically active primary human cells with customized electrophysiological phenotypes for cardiac repair.

Jordan Pomeroy

jordan.pomeroy@duke.edu

I am interested in the fidelity of the electrical system and the role of fibroblasts in cardiac regeneration.

Lingjun Rao

raolingjun@gmail.com

My current project is focused on generating functional skeletal muscle bundles with cells derived from human pluripotent stem cells for drug development, disease modeling and implantation therapies.

Chen Zhaowei

chenzhaowei26@gmail.com

I am interested in developing organ-on-chip platforms containing engineered cardiac and skeletal muscle microtissues to enable high throughput pharmacological and genome editing screening.